Study of NXN 188 for the Treatment of Migraine With Aura
Public ClinicalTrials.gov record NCT00920686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of the Safety and Effectiveness of a Single Oral Dose of NXN 188 for the Treatment of Moderate to Severe Migraine Headache With Aura
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
NXN-188 Dihydrochloride is being developed as an immediate release oral product for the treatment of acute migraine. This study is being conducted to evaluate NXN-188 in subjects with a migraine history of aura.
Study identification
- NCT ID
- NCT00920686
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2009 (Type not available)
- Primary completion
- Mar 2010 (Actual)
- Completion
- Mar 2010 (Actual)
- Last update posted
- Aug 11, 2014
2009 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| C. Philip O'Carrroll, MD, Inc. | Newport Beach | California | 92660 | — |
| The Research Center of Southern California, LLC | Oceanside | California | 92056 | — |
| San Francisco Headache Clinic | San Francisco | California | 94109 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Comprehensive Neuroscience, Inc. | St. Petersburg | Florida | 33702 | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | 66212 | — |
| Michigan Head-Pain and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Headache Care Center/Clinvest | Springfield | Missouri | 65807 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research, LLC | Omaha | Nebraska | 68134 | — |
| Regional Clinical Research, Inc. | Endwell | New York | 13760 | — |
| Elkind Headache Center | Mount Vernon | New York | 10550 | — |
| Rochester Clinical Research, Inc | Rochester | New York | 14609 | — |
| Headache Wellness Center | Greensboro | North Carolina | 27405 | — |
| Coastal Carolina Research Center, Inc | Mt. Pleasant | South Carolina | 29464 | — |
| Advanced Clinical Research, Inc. | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00920686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2014 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00920686 live on ClinicalTrials.gov.